- Unit:
- SINTEF Industry
- Department:
- Biotechnology and Nanomedicine
- Office:
- Trondheim
Started at SINTEF in 1981. Current position is Vice President Marketing with special responsibility in medical technology including nanomedicine. Worked mostly in the field of particle technology, starting with the development of the Dynabeads, then developing micro- and nanoparticles for protection and controlled release of active ingredients for various applications. She is past president of CRS and past chair of ETPN. She is a member of NTVA and the College of Fellows of AIMBE and CRS.
Education
Undergraduate education in organic chemistry (1975) and PhD in physical organic chemistry (1979) from ETH Zürich, Switzerland. Post doc in organic electrochemistry (1980) at NTH, Trondheim, Norway.
Competence and research areas
Research activities include the preparation and characterisation of micro- and nanoparticles and the surface modification of polymers and polymer particles with focus on nanomedicine, targeted drug delivery, nanotechnology-based diagnostics and regenerative medicine. She has long-term experience in translation from lab to pilot scale and has business development experience.
Highlighted publications
- A comparative biodistribution study of polymeric and lipid-based nanoparticles
- A multistep in vitro hemocompatibility testing protocol recapitulating the foreign body reaction to nanocarriers
- The solid progress of nanomedicine
- Delivering the power of nanomedicine to patients today
- Subcellular detection of PEBCA particles in macrophages: combining darkfield microscopy, confocal Raman microscopy, and ToF-SIMS analysis
Projects
- REFINE - Regulatory Science Framework for Nano(bio)material-based Medical Products and Devices
- B-SMART - Brain-Specific, Modular and Active RNA Therapeutics
- EU-NCL – European Nanomedicine Characterization Laboratory
- NanoEFEct – Nanoparticle-Enhanced molecular Fluorescence-Endoscopy for detection of early-stage colorectal adenocarcinomas
- NAREB – Nanotherapeutics for Antibiotic Resistant Emerging Bacterial pathogens
- New one-step process for the preparation of targeting stealth nanoparticles for drug delivery and molecular imaging
- NANOMED2020
- Skin Treat – Develpoment of customized skin treatment and services
Other publications
- PACAB: A nanoparticle technology platform for hard-to-treat cancers
- Publisher Correction: On the issue of transparency and reproducibility in nanomedicine (Nature Nanotechnology, (2019), 14, 7, (629-635), 10.1038/s41565-019-0496-9)
- Compared assay for cell viability tests
- From Drug Discovery to Preclinical Studies: SINTEFs Nanoparticle-Based Technologies for Cancer Treatment
- On the issue of transparency and reproducibility in nanomedicine
- Sonopermeation to improve drug delivery to tumors: from fundamental understanding to clinical translation
- Archaeal tetraether lipid coatings - A strategy for the development of membrane analog spacer systems for the site-specific functionalization of medical surfaces
- Synthesis and Characterisation of organic nanoparticles I and II
- Relationship between polarities of antibiotic and polymer matrix on nanoparticle formulations based on aliphatic polyesters
- Cytotoxicity of Poly (alkyl cyanoacrylate) Nanoparticles